Product Certification&
    Enterprise Certification

  • Mr.simon
    Tel: 86-021-58380978

  • Ms.Cecilia Wei
    Tel: 021-58380978

  • Mobile:13482386415
  • Tel:86-021-58380978
  • Fax:86-021-58380977
  • URL:http://www.systeambc.com
  • Province/state:shanghai
  • City:shanghai
  • Street:Building 87,Lane 669, Dong Jing Road Shanghai,P.R.China
  • MaxCard:
Home > Products >  Baloxavir

Baloxavir CAS NO.1985605-59-1

  • msdsMSDS/COA Download

  • FOB Price: USD: 1.00-1.00 /Gram Get Latest Price
  • Min.Order: 1 Kilogram
  • Payment Terms: L/C,T/T
  • Available Specifications:

    98%(1-100)Gram98%(100-1000)Gram99%(1-100)Gram

  • Product Details

Keywords

  • Baloxavir
  • 1985605-59-1
  • Baloxavir

Quick Details

  • ProName: Baloxavir
  • CasNo: 1985605-59-1
  • Molecular Formula: C??H??F?N?O?S
  • Appearance: white powder
  • Application: Baloxavir
  • DeliveryTime: instock
  • PackAge: 100g,250g,500g,1kg,25kg.....
  • Port: Shanghai tianjin
  • ProductionCapacity: 100 Kilogram/Year
  • Purity: 98%
  • Storage: Store at dry and airtight room tempera...
  • Transportation: normal
  • LimitNum: 1 Kilogram
  • Moisture Content: ≤ 1.0%
  • Impurity: ≤ 2.0%

Superiority

Baloxavir  instock  (We can supply this product in large quantity and the annual output can reach 100kg/month )

 

We are specialized in custom synthesis, chemical/pharmaceutical/ pesticides outsourcing and contract research. 

We are committed to provide excellence in researching, manufacturing and drug discovery process.

 

Our research team of scientists consists of western-trained Ph.D.s with experience and capabilities in drug R&D methodologies and medicinal chemistry.

Details

Description

Baloxavir is an anti-influenza agent extracted from patent WO 2017104691 A1.

IC50 & Target

Influenza virus[1]

Clinical Trial
NCT Number Sponsor Condition Start Date Phase
NCT03653364 Hoffmann-La Roche Influenza December 13, 2018 Phase 3
NCT03629184 Hoffmann-La Roche Influenza December 13, 2018 Phase 3
NCT03684044 Hoffmann-La Roche Influenza November 30, 2018 Phase 3
NCT02954354 Shionogi|Shionogi Inc. Influenza November 1, 2016 Phase 3
NCT02949011 Shionogi|Shionogi Inc. Influenza December 1, 2016 Phase 3
Solvent & Solubility
In Vitro: 

DMSO : ≥ 50 mg/mL (103.41 mM)

* "≥" means soluble, but saturation unknown.

Preparing 
Stock Solutions
ConcentrationSolventMass 1 mg 5 mg 10 mg
1 mM 2.0683 mL 10.3415 mL 20.6830 mL
5 mM 0.4137 mL 2.0683 mL 4.1366 mL
10 mM 0.2068 mL 1.0341 mL 2.0683 mL
*Please refer to the solubility information to select the appropriate solvent.
References

 

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog